Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)

INR 56.84

(0.0%)

Total Assets Summary of Aarey Drugs & Pharmaceuticals Limited

  • Aarey Drugs & Pharmaceuticals Limited's latest annual total assets in 2023 was 3.04 Billion INR , up 4.69% from previous year.
  • Aarey Drugs & Pharmaceuticals Limited's latest quarterly total assets in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • Aarey Drugs & Pharmaceuticals Limited reported annual total assets of 2.91 Billion INR in 2022, up 18.83% from previous year.
  • Aarey Drugs & Pharmaceuticals Limited reported annual total assets of 2.45 Billion INR in 2021, up 5.21% from previous year.
  • Aarey Drugs & Pharmaceuticals Limited reported quarterly total assets of - INR for 2023 Q1, down -100.0% from previous quarter.
  • Aarey Drugs & Pharmaceuticals Limited reported quarterly total assets of 3.04 Billion INR for 2023 FY, up 4.69% from previous quarter.

Annual Total Assets Chart of Aarey Drugs & Pharmaceuticals Limited (2023 - 2008)

Historical Annual Total Assets of Aarey Drugs & Pharmaceuticals Limited (2023 - 2008)

Year Total Assets Total Assets Growth
2023 3.04 Billion INR 4.69%
2022 2.91 Billion INR 18.83%
2021 2.45 Billion INR 5.21%
2020 2.33 Billion INR 20.07%
2019 1.94 Billion INR 33.19%
2018 1.45 Billion INR -14.18%
2017 1.69 Billion INR 18.51%
2016 1.43 Billion INR 14.62%
2015 1.24 Billion INR 8.74%
2014 1.14 Billion INR 7.54%
2013 1.06 Billion INR -0.21%
2012 1.07 Billion INR 23.35%
2011 868.36 Million INR 103.54%
2010 426.63 Million INR 63.33%
2009 261.2 Million INR 69.57%
2008 154.03 Million INR 0.0%

Peer Total Assets Comparison of Aarey Drugs & Pharmaceuticals Limited

Name Total Assets Total Assets Difference
Sigachi Industries Limited 6.94 Billion INR 56.063%
Ind-Swift Limited 6.54 Billion INR 53.399%
Bajaj HealthCare Limited 7.65 Billion INR 60.138%
Sakar Healthcare Limited 3.88 Billion INR 21.527%
Aurobindo Pharma Limited 450.71 Billion INR 99.323%
Innova Captab Limited 13.2 Billion INR 76.91%
Divi's Laboratories Limited 154.7 Billion INR 98.028%
AstraZeneca Pharma India Limited 10.78 Billion INR 71.708%
Morepen Laboratories Limited 12.93 Billion INR 76.416%
Mankind Pharma Limited 119.63 Billion INR 97.451%
Sequent Scientific Limited 15.4 Billion INR 80.2%
Wanbury Limited 3.43 Billion INR 11.209%
Laurus Labs Limited 83.87 Billion INR 96.364%
Nectar Lifesciences Limited 21.91 Billion INR 86.08%
Glenmark Life Sciences Limited 28.5 Billion INR 89.3%
Alembic Limited 23.28 Billion INR 86.903%
Hikal Limited 24.87 Billion INR 87.737%
Alembic Pharmaceuticals Limited 64.45 Billion INR 95.268%
Neuland Laboratories Limited 18.32 Billion INR 83.357%
J. B. Chemicals & Pharmaceuticals Limited 39.94 Billion INR 92.364%
Glenmark Pharmaceuticals Limited 143.58 Billion INR 97.876%
IOL Chemicals and Pharmaceuticals Limited 22.44 Billion INR 86.411%
Themis Medicare Limited 5.66 Billion INR 46.154%
RPG Life Sciences Limited 5.12 Billion INR 40.532%
Zydus Lifesciences Limited 292.8 Billion INR 98.958%
Lupin Limited 239.97 Billion INR 98.729%
Amrutanjan Health Care Limited 3.66 Billion INR 16.867%
Wockhardt Limited 76.49 Billion INR 96.013%
Vaishali Pharma Limited 799.55 Million INR -281.451%
Aarti Pharmalabs Limited 25.82 Billion INR 88.188%
Jagsonpal Pharmaceuticals Limited 2.17 Billion INR -40.499%
Jubilant Pharmova Limited 115.48 Billion INR 97.359%
FDC Limited 24.68 Billion INR 87.643%
Dr. Reddy's Laboratories Limited 387.51 Billion INR 99.213%
Kilitch Drugs (India) Limited 2.4 Billion INR -27.047%
Eris Lifesciences Limited 70.48 Billion INR 95.673%
Venus Remedies Limited 6.26 Billion INR 51.344%
ZIM Laboratories Limited 4.46 Billion INR 31.742%
Bliss GVS Pharma Limited 12.13 Billion INR 74.874%
Par Drugs and Chemicals Limited 1.01 Billion INR -200.156%
Caplin Point Laboratories Limited 26.97 Billion INR 88.693%
Shilpa Medicare Limited 30.93 Billion INR 90.14%
Albert David Limited 4.97 Billion INR 38.756%
Ajanta Pharma Limited 46.38 Billion INR 93.425%
Hester Biosciences Limited 6.62 Billion INR 53.953%
Suven Pharmaceuticals Limited 22.54 Billion INR 86.469%
Solara Active Pharma Sciences Limited 23.46 Billion INR 87.003%
Gufic Biosciences Limited 10.92 Billion INR 72.084%
Windlas Biotech Limited 6.26 Billion INR 51.295%
Procter & Gamble Health Limited 7.94 Billion INR 61.605%
Mangalam Drugs & Organics Limited 3.33 Billion INR 8.527%
Granules India Limited 55.2 Billion INR 94.476%
Aarti Drugs Limited 24.32 Billion INR 87.461%
Bal Pharma Limited 3.2 Billion INR 4.806%
Alkem Laboratories Limited 155.74 Billion INR 98.042%
Sun Pharmaceutical Industries Limited 854.62 Billion INR 99.643%
Lincoln Pharmaceuticals Limited 7 Billion INR 56.448%
Medicamen Biotech Limited 2.94 Billion INR -3.555%
Unichem Laboratories Limited 31.69 Billion INR 90.377%
Bafna Pharmaceuticals Limited 1.47 Billion INR -106.52%
Biofil Chemicals and Pharmaceuticals Limited 470.82 Million INR -547.78%
Valiant Laboratories Limited 3.42 Billion INR 11.0%
Orchid Pharma Limited 15.53 Billion INR 80.372%
Medico Remedies Limited 961.95 Million INR -217.055%
Ind-Swift Laboratories Limited 11.65 Billion INR 73.823%
Ipca Laboratories Limited 111.01 Billion INR 97.253%
Brooks Laboratories Limited 904.45 Million INR -237.211%
Syncom Formulations (India) Limited 4.04 Billion INR 24.631%
Piramal Enterprises Limited 826.05 Billion INR 99.631%
Torrent Pharmaceuticals Limited 150.61 Billion INR 97.975%
NATCO Pharma Limited 69.06 Billion INR 95.584%
Suven Life Sciences Limited 2.84 Billion INR -7.051%
Krebs Biochemicals & Industries Limited 1.78 Billion INR -71.176%
Strides Pharma Science Limited 58.39 Billion INR 94.777%
Indoco Remedies Limited 21.44 Billion INR 85.779%
Alpa Laboratories Limited 1.82 Billion INR -67.008%
Lasa Supergenerics Limited 1.5 Billion INR -102.157%
Sun Pharma Advanced Research Company Limited 5.15 Billion INR 40.783%